<DOC>
	<DOCNO>NCT00971724</DOCNO>
	<brief_summary>Primary objective : - To identify biomarker biomarker-set adverse metabolic effect various dos prednisolone treatment . Secondary objective : - To describe PK prednisolone PD series biomarkers . - To identify biomarkers reflect side effect prednisolone . - To elucidate part mechanism prednisolone induce metabolic change .</brief_summary>
	<brief_title>Biomarkers Prednisolone Treatment ( P05888 )</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>22 &lt; BMI &lt; 30 fast glucose &lt; 5.6 mmol/L glucose &lt; 7.8 mmol/L 2hr OGTT able willing sign inform consent history good physical mental health subject smoke le 5 cigarette per day able keep normal day night rhythm allergy prednisolone glucocorticoid use last 3 month prior study use drug substance history familiar diabetes type 2 clinically relevant history presence medical disorder clinically relevant abnormal lab ECG positive drug alcohol screen , positive hepatitis B C surface antigen donation blood ( &gt; 100 mL ) within 90 day prior first dose</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Prednisolone</keyword>
	<keyword>Glucocorticoids</keyword>
</DOC>